The assessment is based on a single, highly authoritative and relevant primary source: a press release from Enlivex itself. This source directly confirms the core elements of the statement: the company (Enlivex), the amount to be raised ($212 million), and the purpose (to initiate its "RAIN Strategy"). The statement's specific terminology, such as "Rain Token Treasury" and "Prediction-Market DAT," is not explicitly present in the provided summary of the press release. However, these terms are highly consistent with a crypto-related initiative named the "RAIN Strategy." It is plausible that these are details of the strategy described within the full press release. The source identifies the fundraising mechanism as a "private placement," while the statement says it is "in a Prediction-Market DAT." These are not necessarily contradictory; the private placement could be the method used to secure the $212 million, with the funds then being allocated to a treasury governed by the DAT. The other provided sources are entirely irrelevant to the claim, discussing clinical trial data or different companies, and therefore do not support or contradict the statement. Given the strong confirmation of the main facts from the company's own press release, the statement is assessed as likely true, with a minor uncertainty reserved for the specific jargon not explicitly verified by the source summary.